ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

RVNC Revance Therapeutics Inc

3.03
-0.13 (-4.11%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 25.26M28.37M29.02M49.92M49.33M58.13M56.78M69.8M
Operating Income -62.22M-57.84M-77.48M-144.41M-58.03M-65.5M-139.29M-53.95M
Pre Tax Income -64.34M-61.44M-83.99M-145.95M-59.79M-67.32M-140.88M-55.7M
Net Income -64.34M-61.44M-84.69M-145.95M-59.79M-67.32M-141.18M-55.7M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -62.44M-58.12M-77.37M-146.21M-58.27M-66.1M-139.52M-53.74M
EBITDA -56.85M-52.39M-72.05M-57.16M-51.41M-61.97M-43.99M-52.53M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 300k262k3.73M413k15.33M77.8M132.57M234.04M
Operating Income -79.16M-117.5M-142.63M-164.46M-273.16M-274.68M-341.96M-316.78M
Pre Tax Income -89.27M-120.59M-139.57M-159.43M-284.71M-281.31M-355.72M-323.69M
Net Income -89.27M-120.59M-142.57M-159.43M-282.09M-281.31M-356.42M-323.99M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -3.156-3.302-3.856-3.044-4.078-3.93-4.326-3.689
EBIT -79.69M-118.02M-143.41M-164.76M-273.75M-275.44M-344.14M-317.62M
EBITDA -77.71M-116M-140.91M-161.55M-262.91M-254.82M-238.44M-209.9M

Your Recent History

Delayed Upgrade Clock